These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 11188777

  • 21. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A, Bakke AC, Hopke C, Dwyer J, Vandenbark AA, Offner H.
    J Neurosci Res; 2004 Jul 01; 77(1):119-26. PubMed ID: 15197745
    [Abstract] [Full Text] [Related]

  • 22. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M, Dubucquoi S, Lefranc D, Zéphir H, De Seze J, Vermersch P, Prin L.
    Immunol Lett; 2005 Jan 15; 96(1):11-26. PubMed ID: 15585303
    [Abstract] [Full Text] [Related]

  • 23. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.
    Jadidi-Niaragh F, Mirshafiey A.
    Neuropharmacology; 2010 Sep 15; 59(3):180-9. PubMed ID: 20493888
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V, Taradi SK, Andreis I, Zupancić V, Taradi M.
    Lijec Vjesn; 2001 Sep 15; 123(3-4):81-8. PubMed ID: 11488222
    [Abstract] [Full Text] [Related]

  • 34. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L, Zamvil SS.
    Trends Immunol; 2005 Nov 15; 26(11):565-71. PubMed ID: 16153891
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Palaszynski KM, Liu H, Loo KK, Voskuhl RR.
    J Neuroimmunol; 2004 Apr 15; 149(1-2):84-9. PubMed ID: 15020068
    [Abstract] [Full Text] [Related]

  • 38. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL.
    Int Immunol; 2006 Apr 15; 18(4):537-44. PubMed ID: 16481342
    [Abstract] [Full Text] [Related]

  • 39. [Pathology and pathogenesis of multiple sclerosis from the viewpoint of neurologic disease research].
    Seitelberger F.
    Wien Med Wochenschr; 1985 Jan 31; 135(1-2):6-7. PubMed ID: 3976241
    [Abstract] [Full Text] [Related]

  • 40. Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids.
    El-Etr M, Ghoumari A, Sitruk-Ware R, Schumacher M.
    Maturitas; 2011 Jan 31; 68(1):47-51. PubMed ID: 21035281
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.